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Abstract. We have investigated the topology of the a
and S subunits of the nicotinic acetylcholine receptor
(AChR) from mammalian muscle synthesized in an in vi-
tro translation system supplemented with dog pancreatic
microsomes. Fusion proteins were expressed in which
a carboxy-terminal fragment of bovine prolactin was
attached downstream of each of the major putative
transmembrane domains, Ml-M4 and MA, in the AChR
subunits. The orientation of the prolactin domain rela-
tive to the microsomal membrane was then determined
for each protein by a proteolysis protection assay. Since
the prolactin domain contains no information which
either directs or prevents its translocation, its trans-
HE nicotinic acetylcholine receptor (AChR),' which
is found at the neuromuscular junction in vertebrate
skeletal muscle and at the endplates of electric organs,
is a pentameric complex composed offour glycoprotein sub-
units in an a28,yb stoichiometry (10). The subunits are ar-
ranged pseudosymmetrically around a central ion channel
(40, 53). A comparison of the primary sequences ofthe sub-
units of the AChR reveals a high degree of homology both
within and across species boundaries (52) . The AChR is the
best-studied member of a super-family of ligand-gated ion
channels which includes the GABAA, glycine, and neuronal
nicotinic acetylcholine receptors (20, 43, 51) . All of these
channels are hetero-oligomers whose subunits are highly ho-
mologous, suggesting that they are derived from a common
evolutionary precursor.
The subunits of the AChR and related channels also share
a common domain structure. Hydropathic analysis ofthe pri-
mary sequence reveals five regions of high hydrophobicity
comprised of an amino-terminal signal sequence (1, 2, 4) and
four regions of sufficientlength to form (Y-helical transmem-
brane domains (Ml through M4) (11, 15, 41). This domain
pattern has led to a structural model of the AChR subunits
in which the amino and carboxy termini are on the extracel-
lular side ofthe membrane separated by four transmembrane
1. Abbreviations used inthispaper: AChR, acetylcholine receptor; CIP, calf
intestinal phosphatase; PK, proteinase K.
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membrane orientation depends solely on sequences
within the AChR subunit portion of the fusion protein.
When subunit-prolactin fusion proteins with the pro-
lactin domain fused after either M2 or M4 were tested,
prolactin-immunoreactive peptides that were larger
than the prolactin domain itself were recovered . No
prolactin-immunoreactive peptides were recovered after
proteolysis of fusion proteins containing prolactin
fused after Ml, M3, or MA. These results support a
model of AChR subunit topology in which Ml-M4,
but not MA, are transmembrane domains and the car-
boxy terminus is extracellular.
domains (Ml-M4) and a long cytoplasmic loop between M3
and M4 (see Fig. 1).
Although this model is commonly accepted, experiments
on the topological arrangement of the AChR subunits have
yielded conflicting results, leading to several alternative
models of subunit structure. An amphipathic transmem-
brane domain between M3 and M4 (designated MA) was
proposed on the basis of primary sequence analysis (17, 22),
placing the carboxy terminus on the cytoplasmic side of the
membrane. Epitope mapping experiments support models
with a pair of transmembrane domains in the region before
Ml (12, 44, 48), and other immunochemical and biochemi-
cal experiments support models with zero (48), one (16, 37),
or two (17, 22, 56) transmembrane domains beyond M3.
Thus, models with three to seven transmembrane domains
can be constructed.
As an approach to this problem, we have investigated the
transmembrane orientation of the AChR subunits synthe-
sized in an in vitro translation system from rabbit reticulo-
cytes supplemented with dog pancreatic microsomes. In ear-
lier experiments, we investigated the topology of the amino
terminal domain of the a subunit using glycosylation con-
sensus sequences as reporter domains (8) . In the present
study, we fused a reporter domain derived from bovine
prolactin to the a and S subunits of the AChR after each of
the proposed transmembrane domains beyond Ml (Ml-M4
and MA) and expressed these constructs in the in vitro trans-
lation system . The accessibility of this reporter domain to
385proteolytic enzymes was used to determine its orientation
relative to the microsomal membrane. The results of these
experiments, taken with our earlier findings, demonstrate
that the amino and carboxy termini of the subunit polypep-
tides are sequestered within the vesicle and are separated by
four transmembrane domains.
Materials and Methods
Subunit Clones and Molecular BiologyReagents
The clones for the a and S subunit cDNAs ofthe mouse muscle AChR (26,
30) wereobtained from Drs. J. P. Merlie (Washington University, St. Louis,
MO) and N. Davidson (California Institute of Technology). The plasmids
pSP BPI, which contains the cDNA for bovine prolactin, and pSP Ptr, a
truncated formofpSP BPI which contains the cDNAfor the carboxy termi-
nal 142 amino acid residues of bovineprolactin, were generous gifts of Dr.
V. R. Lingappa (University of California at San Francisco) and have been
characterized elsewhere (35, 49). Several vectors (pGEM 1, pGEM 2,
pSP72, pSP73) were obtained commercially (Promega Biotec, Madison,
WI). The vector pSM was generously provided by M. Brodsky and Dr. D.
Littman (University of California at San Francisco) (7). All enzymes were
obtained commercially from either Promega Biotec, New England Biolabs
(Beverly, MA), Boehringer Mannheim Biochemicals (Indianapolis, IN), or
Bethesda ResearchLaboratories (Bethesda, MD) . Sequencing ofconstructs
was performed with the Sequenase kit (US Biochemicals, Cleveland, OH) .
Oligonucleotides used in the creation of new restriction sites in the a and
S subunit sequences were obtained from eitherthe Biornolecular Resource
Center at University ofCalifornia at San Francisco or were synthesized by
Dr. P Garcia (University of California at San Francisco). Thble I details
the amino acid sequences at the subunit-prolactin fusion points.
pGEMPJ. The plasmidpGEM PI, which has several restriction sites up-
stream of the coding region for the carboxy terminal 142 amino acid
residues ofbovine prolactin, was constructed to facilitate the cloning of the
prolactin fragment into the subunit coding regions. The vector pGEM1 was
digested with Smal and calf intestinal phosphatase (CIP), and was ligated
to theHincII/PvuIIfragment from pSP BPIovernightat 16°C with T4 DNA
ligase.
a Subunit-Prolactin Fusion Proteins
c,PMJ. The construct pSM am was altered by oligonucleotide-directed
mutagenesis (8, 19, 28) to create an SmaI site in the region between the first
and second transmembrane domains. The resulting plasmid, pSM ceA869,
was digested with Smal and CIP. pGEM PI was digested with HincH and
EcoRI, and the fragment was blunted with the Klenow fragment of DNA
polymerase. This fragment was ligated with theSmal-digested pSM ciA869
to yieldpSM aPMI. Tb createpSP73 aPMI, pSP73 was first digested with
SphI and EcoRI, andtreated with CIP pSM aPMI was digested with SphI
and EcoRI, and the fragment was ligated into the digested pSP73.
aPM2. The construct pSM am was altered to create an HpaI site in the
region between the second and third transmembrane domains. This con-
struct, pSM aA967, was digested with EcoRI and XmnI to excise the
modified a subunit coding region, and this fragment was ligated into
pGEM2 cut with EcoRl and Smal and treated with CIP The construct
pGEM2 aPM2 was created by digestion of pGEM2 ciA967 with HpaI and
CIP, into which the HincH/EcoRl/Klenow fragment from pGEM PI was
ligated (see above).
aPM3. A new Hpa I site was created in the region between the third
transmembrane domain and the putative amphipathic helix in the construct
pSM am. This construct, pSM aA1158, was digested with EcoRI/XmnI,
and ligated into pGEM2 digested with SmaI/EcoRI/CIP pGEM2 aPM3
was prepared by digestion of pGEM2 ciA1158 with HpaI and CIP, into
which the HincII/EcoRI/Klenow fragment from pGEM PI was ligated.
aPMA. A new BarnHIsite was created in the region betweenthe putative
amphipathic helix and fourth transmembrane domain of pSM am. This
construct, pSM aA1346, was digested with EcoRI/BarnHIand the fragment
was inserted into the plasmid vector pSP73 prepared by digestion with
EcoRI/BamHI/CIP Tb create pSP73 aPMA, pSP73 aA1346 was digested
with BamHI/SphI/CIP, and a BamHI/SphI fragment from pGEM PI was
ligated into the prepared vector.
aPM4. The construct pSM am was altered to create an Hpal site in the
carboxy-terminal tailofthe a subunit beyond the fourth transmembrane do-
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main. The modified a subunit coding region was excised from the resulting
construct, pSM aA1453, by digestion with EcoRl and XmnI, and was
ligated into pGEM2 that hadbeen digested with SmaI/EcoRI/CIP. pGEM2
aA1453 was digested with BamHI/Hpal/CIP. pSP BPI was digested with
Pvull and BamHI, and the fragment was ligated into the digested pGEM2
aA1453 to create pGEM2 ciPM4.
S Subunit-Prolactin Fusion Proteins
SPM2. pSP73 Sm was prepared as a vector by complete digestion with
NcoI, followed by Klenow treatment and digestion with Pstl and CIP. A
HincII/Pstl fragment from pGEM PI was ligated into this site to create
pSP73 SPM2.
SPM3. pSP73 Sm was digested with Stul and Pstl and treated with CIP
A HincII/PstI fragment of pGEM PI was ligated into the prepared pSP Sm
vector to create pSP SPM3.
SPMA. The construct pSM Sm was modified to create an Hpal site in
the regionbetween the putative amphipathic helix and thefourth transmem-
branedomain. Thealtered d subunitcDNA (01411), excised from this con-
struct by digestion with EcoRl and Xbal, was ligated into pSP73 that had
been digested with EcoRI/Xbâl/CIP pSP73 6D1411 was digested with Hpal
andCIP, and a HincII/EcoRl/Klenow fragment from pGEMPI was inserted
into the prepared vector. This construct was designated pSP73 SPMA.
SPM4. The construct pSP73 Sm was prepared by digestion with Pstl,
SphI, and CIP A Pstl/SphI fragment from pGEM PI was ligated into the
prepared vector. This construct was designated pSP73 SPM4.
In Vitro Transcription and 71"anslation
Capped transcripts were synthesized fromunlinearized plasmid DNA as de-
scribed previously (8, 38) except thatthe digestionwith RNAse-free DNAse
at the end of the transcription was omitted. The synthesized transcript was
extracted with phenol/chloroform, precipitated with ethanol, and resus-
pended in RNAse-free water. Micrococcal nuclease-treatedrabbit reticulo-
cyte lysate and canine pancreatic microsomes were prepared as described
(27, 54). The translations were performed as described (8). All translations
included caninepancreatic microsomes, except those used in Fig. 3. At the
end ofthe incubation the tubes were placed on ice, and a solution of CaC12
was added to a final concentration of 10 mM.
Proteolysis and Immunoprecipitation
Aliquots from the in vitro translation were prepared for digestion with pro-
teinase K (PK; Sigma Chemical Co., St. Louis, MO). Tb 9 pl ofthetransla-
tion mixture, either 1 p.l water, or 1 Al of 100 Pg/ml PK (predigested for
30 min at 37°C), or 1 pl of 100,ug/ml PK plus 1.2 JAI 10% Triton X-100
was added, and the digests were incubated on ice for 1.h. At the end of the
digestion, PMSF was added quickly to the reaction mixture to a concentra-
tion of 2 mM, and the entire mixture was plunged into 100 Al of 1% SDS
in 100 mM Tris-HC1(8.0) in a boiling water bath. After 10 min of boiling,
a 50-p1 aliquot of the sample was diluted with a solubilization buffer con-
taining 1.25% Triton X-100, 50 mM NaCl, 1 mM EDTA, 1 mM EGTA,
50 mM Tris-HCI (7.4), 0.02% NaN3 to make the Triton/SDS ratio 5:1 (1%
Triton/0.2 % SDS).
Prolactin antiserum (US Biochemicals) was diluted 1:10 with 50 mM
iris-HCI (7.4), 0.02% NaN3. 2 Al of this antiserum was added to 250 Al
of the Triton-solubilized proteolysis mixture and incubated for 2 h on ice.
15 pl of a 1:1 slurry of prewashed protein A-Sepharose (Pharmacie Fine
Chemicals, Piscataway, NJ) was added, and incubated for 1-2 h with agita-
tion at 4°C. Atthe endofthe incubation, thebeads were pelleted and washed
twice with 500 pl 1% Triton X-100, 100 mM NaCl, 10 mM EDTA, 10 MM
EGTA, 100 mM Tris-HCI, pH 8.0. PAGE gel loading buffer with 5%
ß-mercaptoethanol was added, the sample was heated to 100°C for 3 min
and was subjected to SDS-PAGE (29). The gels were stained, fluorographed,
and exposed to Hyperfilm MP (Amersham Corp., Arlington Heights, IL).
Three different antibodies were used to characterize the a subunit-
prolactin constructs: mAb 210 (a rat mAb which has been mapped to
a68-76 [14]), mAb 61 (a rat mAb which has been mapped to a371-386
[48]), and the prolactin antiserum described above. mAbs 210 and 61 were
the generous gifts of Dr. J. Lindstrom (University of Pennsylvania). Ttvo
antibodies were used to characterize the S subunit-prolactin constructs:
mAb 88B (a mouse mAb that has been mapped to the cytoplasmic loop be-
tween M3 and M4 [181) and the prolactin antiserum. mAb 88B was the
generous gift of Dr. S. C. Froehner (Dartmouth University) . Fig. 2 shows
the location of the mAb epitopes on the primary sequences of the a and
S subunits. Aliquots (5 pl) weretaken from the in vitro translation reactions
386Table I . Sequences at thejunction points in theAChR
subunitprolactin fusion proteins"
Construct
￿
Sequence
aPMlt . . . 234YLPTDS DSRGSP CHTSSL . . .
aPM2
￿
. . .Z 6eSTS SAVDSRGSP CHTSSL . . .
aPM3$ . . . 329MKRPSRVDSRGS PCHTSSL . . .
aPMA . . . 39'ESNNAAEGSP CHTSSL . . .
aPM4t . . . 426FAGRLIEFCHTSSL . . .
BPM2t . . . 278LPATSMDSRGSP CHTSSL . . .
SPM3
￿
. . . 39'RLTTARRDSRGSP CHTS SL . . .
SPMA . . . 443QVARTVDSRGSP CHTSSL . . .
6PM4t . . . 465AWIFLQVDSRG SPCHTSSL . . .
' Amino acid sequences at the fusion points of the subunit-prolactin con-
structs, given in single-letter code . Amino acids derived from the AChR
subunit coding sequences are in PLAINtext, amino acids derived fromprolac-
tin coding sequences are BOLD, and amino acids derived from vector se-
quences are UNDERLINED . Number to the right of the sequence indicates
the position along the mature subunit sequence ofthe first amino acid residue
given .
$ Constructs sequenced for confirmation . All others predicted from construc-
tion protocol as well as immunoprecipitation results (Figs. 3 and 4) .
and diluted to 50 pl with 2 mMPMSF in PBS . This sample was added to
200 Wl of solubilization buffer and immunoprecipitated as described above,
except that either rabbit-anti-rat-Sepharose (for mAb 210 andmAb 61) or
mAb 88B-Sepharose was used instead of protein A-Sepharose.
Results
We investigated the transmembrane topology of the a and 6
subunits of the AChR in a rabbit reticulocyte lysate in vitro
translation system supplemented with dog pancreas micro-
somes. Fusion proteins were constructed in which a fragment
of prolactin used as an antigenic marker (reporter domain)
was placed after each of the postulated membrane-spanning
domains of theAChR subunits. After synthesis of these con-
structs in vitro, the position ofthe marker with respect to the
microsomal membrane was determined by proteolysis of the
intact microsomes . The rationale of these experiments is
that ifthe prolactin marker is translocated into the lumen of
the microsome (topologically equivalent to the extracellular
space) it will be protected from proteolysis, whereas if the
marker remains outside the vesicle (i.e., the cytoplasmic
surface) it will be susceptible. Once the location of the pro-
lactin marker domain is determined for each construct in the
series, we could then determine whether each of the postu-
lated domains spans the membrane or not .
Construction ofthe Fusion Proteins
A schematic diagram of the fusion proteins that we con-
structed is given in Fig . 2 . The prolactin fragment (M* =
18) was introduced after each of the segments Ml-M4 and
Figure 1. Diagram of the pre-
dicted transmembrane topol-
ogy of the subunits of the
AChR, based on the hydro-
phobicity of the primary se-
quence (11, 15, 41) .
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Figure 2 . Diagram of the
AChR subunit-prolactin fusion
proteins . (A) a subunit-prolac-
tin fusions ; (B) S subunit-pro-
lactin fusions . Chimeranames
are given at the left . For each
construct, the AChR subunit
sequences are denoted by the
open box (with the putative
transmembrane domains Ml-
M4 andMA given as stippled
boxes), and the prolactin se-
quences denoted by the black
box. Details ofthe amino acid sequences at thejunction points are
given in Table I . The locations of the epitopes formAbs mAb 210,
mAb 61, and mAb 88B are indicated.
MA of the a subunit, and after M2-M4 and MA of the 6
subunit . The specificities of the antibodies thatwe used and
the structures of the polypeptides encoded by our constructs
were verified by immunoprecipitation after in vitro transla-
tion . The prolactin fragment, expressed alone, was recog-
nized by the antiserum to prolactin, but not by antibodies to
the a or 6 subunits (Fig . 3 A) ; conversely, the prolactin an-
tiserum recognized neither the intact a subunit (Fig . 3 B,
lane c) nor 6 subunit (Fig . 4 A, lane d) .
The fusion proteins were then tested . All ofthe a subunit-
prolactin constructs were immunoprecipitated with the an-
tiserum to prolactin and with an antibody (mAb 210) that
recognizes an epitope in the amino terminal domain of the
a subunit (Figs. 2A and 3 B) . Only those with the prolactin
fragment inserted afterMA(aPMA andaPM4) wereimmu-
noprecipitated withmAb 61, an antibody that recognizes an
epitope in the segment between M3 and M4 (Fig . 2A ; Fig .
3 B, lanes n and q) . Similarly, all of the 6 subunit-prolactin
constructs were immunoprecipitated with the antiserum to
prolactin, but onlySPM3, SPMA, and BPM4 were immuno-
precipitated withmAb 88B (Fig . 4 B, lanes c, e, and g) . The
mAb 88B epitope is known to be located in the loop between
M3 and M4 (Fig. 2 B) (18) ; since the prolactin domain in
SPM3 was inserted-85 amino acids after the end of M3, the
epitope must lie within this 85 amino acid stretch . These
results show that the a subunit- and B subunit-prolactin fu-
sion proteins were synthesized correctly, with a prolactin-
immunoreactive domain located downstream from each of
the transmembrane domains in the mouse a and B subunits .
Protease Digestion of the a Subunit-Prolactin
Fusion Proteins
We then investigated whether the prolactin domain in each
of the subunit chimeras was translocated into the micro-
somal lumen or remained outside the vesicle . The polypep-
tides were expressed in vitro and the microsomes containing
the newly synthesized polypeptides were subjected to proteo-
lytic digestion with proteinase K (PK) and immunoprecipi-
tated with the prolactin antiserum . When the fivea subunit-
prolactin constructs were tested, prolactin-immunoreactive
peptides were recovered from aPM2 and ciPM4 (Fig . 5 A,
lanes e and n), but not from c&Ml, otPM3, or aPMA (Fig.
5 A, lanes b, h, and k) . When Triton X-100 was added before
the digestion, no prolactin-immunoreactive peptides were
recovered in any case (Fig . 5 A) . Thus, the prolactin domains
387Figure 3 Characterization of prolactin fragment and a subunit-prolactin fusion proteins . (A) Immunoprecipitation of truncated prolactin
fragment . A fragment of bovine prolactin encoding the carboxy-terminal 142 amino acids was expressed in vitro, solubilized in a Triton
X-100 buffer, and immunoprecipitated with either the prolactin antiserum (lane a), a subunit-specific mAbs 210 (lane b) and 61 (lane
c), or S subunit-specific mAb 88B (lane d) . (B) Immunoprecipitation ofasubunit-prolactin fusion proteins . The indicated transcripts (Tr)
were expressed in vitro, solubilized, and immunoprecipitated with either mAb 210 (2), mAb 61 (6), or the prolactin antiserum (P).
in ciPM2 and aPM4 were protectedand must lie within the
lumenofthe microsomes, whereas the prolactindomains in
aPMI, aPM3, and aPMA are exposed on the cytoplasmic
surface of the microsomes . These results indicate that Ml,
M2, M3, andM4 traverse themembrane, but thatMA does
not .
Comparison of the size of the fragments recovered from
proteolysis of thea subunit-prolactin constructs with those
resulting from digestion of the native a subunit (Fig . 5 B)
are consistent with this conclusion . Synthesis of the a
subunit in vitro gave rise to two bands, representing the
glycosylated andunglycosylated forms ofthea subunit (8) .
Immunoprecipitation with mAb 210 after proteolysis of
microsomes containing thea subunit yieldedtwo additional
Figure 4. Characterization ofS subunit and S subunit-prolactin fusion proteins . (A) Proteolysis and immunoprecipitation of normal S sub-
unit . The normal S subunit was expressed in the presence of microsomes. The translation mixture was either left untreated or digested
with proteinaseK (PK) in the absence or presence of Triton X-100 (DET) as described in MaterialsandMethods . The solubilized mixture
was immunoprecipitated with either mAb88B (lanes a-c), or the prolactinantiserum (lanes df ) . (B) Immunoprecipitation of S subunit-
prolactin fusionproteins . The indicated transcripts (Tr) were expressed in vitro in the presence ofmicrosomes, solubilized, andimmunopre-
cipitated with either mAb 88B (8) or the prolactin antiserum (P) .
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Figure S . Proteolysis and im-
munoprecipitation of a sub-
unit-prolactin fusion proteins .
The indicated transcripts (Tr)
were expressed in vitro in the
presence ofmicrosomes . The
translation mixtures were ei-
ther left untreated or digested
with proteinase K (PK) in the
absence or presence of Triton
X-100(DM as described in
Materials and Methods . (A)
Immunoprecipitation with the
prolactinantiserum . Large ar-
rowhead at left indicates the
migrationoftheprolactinfrag-
ment . (B) Immunoprecipita-
tion with mAb 210 . Note re-
versal of lanes n and o . Small
upwards arrowhead in lane e
indicates migration of small-
est mAb 210-immunoreactive
fragment derived from ciPMI .bands of 38 and 36 kD (Fig. 5 B, lane b) . Protected frag-
ments ofthe same size were obtainedwhen microsomes con-
taining either ciPM3 or aPM4 were immunoprecipitated
with mAb 210 after PK digestion (Fig. 5 B, lanes k and n) .
These results suggest that the cytoplasmic segment between
M3 andM4 is the principal site ofPK attackofthea subunit,
and that little proteolysis occurs between Ml and M2 . The
segment betweenMl andM2may not be susceptible because
of its short length, which is predicted to be <10 amino acids
long . The results obtained after mAb 210 immunoprecipita-
tion ofthe proteolytic products ofPK digestion ofaPMI and
ciPM2 demonstrate that the short loop between Ml and M2
is not accessible to PK . The size of ciPM2 was unaffected
by PK digestion, whereas digestion of ciPMI yielded a
smaller fragment (x+32kD) which is recognized bymAb 210
(Fig . 5 B, lane e) and which is similar in size to the primary
translation product of a truncated a subunit cDNA that ter-
minates just after Ml at otG240 (8) . Thus the prolactin frag-
ment is removed in ciPM1, but not aPM2, and the segment
between Ml and M2 is not cleaved .
This analysis of the proteolytic products immunoprecipi-
tated by mAb 210 allows rationalization of the sizes of the
protected prolactin-immunoreactive fragments seen with
ciPM2 and aPM4 (Fig . 5 A, lanes e and n) . Proteolysis of
ciPM2 yielded a full-length prolactin-inununoreactive pep-
tide, indicating that the polypeptide chain ofaPM2 was not
accessible to PK attack . For ciPM4, in contrast, a single
prolactin-immunoreactive fragment of ti22 kD was ob-
tained (Fig . 5 A, lane n) . This peptide is presumably slightly
larger than the prolactin peptide (Fig . 3 A) because of the ad-
ditional amino acids that comprise M4 .
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Figure 6. Proteolysis and immunopre-
cipitation of 6 subunit-prolactin fusion
proteins. The indicated transcripts (Tr)
were expressed in vitro and treated as
described in Fig . 5 . The solubilized mix-
ture was immunoprecipitated with the
prolactin antiserum. Note reversal of
lanes a and b. Large arrowhead at right
indicates the migration of the prolactin
fragment .
Protease Digestion ofthe 6 Subunit-Prolactin
Fusion Proteins
The pattern of protection seen with the 6 subunit-prolactin
fusion proteins after PK digestion and immunoprecipitation
with the prolactin antiserum was similar to that of the a
subunit-prolactin fusion proteins (Fig . 6) . The entire 6PM2
polypeptide was immunoprecipitated with the prolactin anti-
serum after digestion with PK (Fig . 6, lane b), whereas a
small fragment of 6PM4 slightly larger than the prolactin
peptide (23 kD) was recovered (Fig . 6, lane k) . No fragments
of the normal 6 subunit were recovered after digestion with
PK, whether immunoprecipitated by mAb 88B or the pro-
lactin antiserum (Fig . 4 A) . As with otPM4, the prolactin-
immunoreactive fragment recovered after PK digestion of
BPM4 was slightly larger than the prolactin polypeptide (Fig .
6, lane k) . No prolactin-immunoreactive fragments were re-
covered after the proteolysis of either 6PM3 or 6PMA (Fig .
6, lanes e and h) . Therefore, for analogous a- or 6-subunit-
prolactin chimeras, the location of the prolactin domain is
identical . For either subunit, when placed after Ml, M3, or
MA, the prolactin domain remained accessible to proteoly-
sis, indicating that the regions that follow these domains are
oriented outside of the microsome (cytoplasmic in vivo) .
When placed after either M2 or M4, however, the prolactin
domain was inaccessible to proteolysis, indicating that the
carboxy terminal ends ofM2 andM4 are oriented within the
microsome (extracytoplasmic in vivo) .
Discussion
We have made a systematic investigation of the transmem-
390brane topology of the subunits of the mammalian muscle
AChR in an in vitro translation system by inserting a prolac-
tin reporter domain after each of the major proposed trans-
membrane domains. Our experiments demonstrate that the
carboxy termini of the newly translated, unassembled a and
S subunits of the AM reside in the lumen of the ER, indi-
cating that the subunit polypeptides span the membrane an
even number of times. Furthermore, our results are consis-
tent with a topological model in which the AChR subunits
span the membrane at least four times and in which Ml-M4
traverse the membrane but MA does not. Thus prolactin do-
mains placed to the carboxy-terminal side of Ml, M3, and
MA are susceptible to proteolysis, whereas those placed af-
ter M2 and M4 are protected.
Most previous experiments on the AChR have used anti-
bodies to determine the location of specific regions on par-
ticular subunits in the intact receptor (12, 13, 18, 31, 32, 33,
34, 44, 46, 47, 48, 50, 56) . Such studies have been limited
to regions for which antibodies are available and in some
cases by the specificity of the antibodies used. Our approach
differs from these experiments in two ways. First, we have
identified transmembrane regions by determining the orien-
tation of a neutral reporter domain whose susceptibility to
proteolysis we can detect reliably using specific antibodies.
Reporter domains have been used widely and successfully to
study the topology ofother polytopic membrane proteins (5,
6, 9, 21, 36, 57). A possible disadvantage of this use of a
reporter domain is that its introduction coulddisrupt the nor-
mal topology of the subunits. To minimize this possibility,
we chose for our experiments a cDNA fragment encoding a
carboxy-terminal region of bovine prolactin of -142 amino
acids in length (predicted molecular mass 16,786 D) . This
fragment lacks the codons for the signal sequence found in
full-length prolactin and has been shown to be topogenically
neutral when used as a reporter in other experiments (45, 49,
55) . Thus, its transmembrane orientation in our experiments
presumably is determined solely by topogenic elements
within the AChR subunit sequences. The addition of the
prolactin domain is also unlikely to disturb the topology of
the AChR subunit in the regions examined as experiments in
other systems have shown that the removal of downstream
topogenic domains does not affect the topology of upstream
regions (6, 36) and that topogenic domains exert their func-
tion on nonnative domains in predictable ways (49, 55).
A second feature of our experiments is the use of an in
vitro translation system to give information abouttransmem-
brane orientation. Although assembly of the intact receptor
has not been achieved invitro, subunits in an in vitro transla-
tion system supplemented with microsomes are faithfully
synthesized, inserted into the membrane, glycosylated, and
their signal sequences cleaved (1, 3, 8) . In vitro experiments
have the advantage that the translocation of domains in
subunits can be investigated in constructs that may not un-
dergoassembly and transport to the cell surface and may not
form functional AChR. Transmembrane domains that arise
from subsequent rearrangements during assembly, however,
might not be detected (see below) .
The amino termini ofAChR subunits expressed in vitro are
translocated into the lumen of microsomal vesicles (equiva-
lent topologically to the extracellular space) as are the amino
termini of the native AChR subunits (Fig. 5) (1, 3, 8). Al-
though the experiments described here offer no information
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on theposition and number of transmembrane regions on the
amino-terminal side ofMl, we have previously described ex-
periments in vitro showing that an a subunit fragment ter-
minating at position a207 is not an integral membrane pro-
tein and that novel glycosylation sites introducedat positions
a154 and a200 are on the lumenal side ofthe membrane (8).
These findings, which are consistent with previous data on
the amino-terminal signal sequence, the glycosylation sites,
and the location of the binding site for a-bungarotoxin in the
intact AChR (10), suggest that the entire amino-terminal do-
main preceding Ml is translocated into the microsomal
lumen.
Our experiments show that in the newly synthesized a
subunit both Ml and M2 span the membrane and do so in
opposite directions. The peptide containing the amino-ter-
minal domain, Ml, and a carboxy-terminal prolactin domain
(ciPM1) is, in contrast to the ct207 fragment, an integral
membrane protein and has the prolactin domain on the cyto-
plasmic side; when placed after M2 (in both aPM2 and
SPM2), the prolactin domain is lumenal. By a similar argu-
ment, M3 and M4 are also transmembrane domains. The as-
signment ofMl-M4 as transmembrane domains is consistent
with experiments in oocytes showing that after deletion of
any of the segments Ml-M4 functional AChRs are not ex-
pressed (39).
Our observation that the carboxy termini of the a and S
subunits arelocated on the lumenal side ofthe membrane are
supported by previous experiments demonstrating that the
AChR oligomers of Torpedo are linked as dimers via an ex-
tracellular disulfide bond between cysteine residues near the
carboxy terminus ofneighboring S subunits (16, 23, 37) . Ear-
lier reports based on immunocytochemical localization (47,
48, 56) placed the carboxy terminus on the cytoplasmic side
of the membrane.
Our results clearly indicate that MA is cytoplasmic, con-
sistent with earlier immunochemical studies (47, 48) . Thus,
prolactin domains placed on either side of MA are suscepti-
ble to proteolysis. Because MA is amphipathic, one might
argue that MA does not adopt a transmembrane orientation
until the AChR oligomer is assembled. To be compatible
with a placement of the carboxy terminus on the extracellu-
lar side ofthe membrane, however, this hypothesis would re-
quire either that the polypeptide chain traverse the mem-
brane twice between M3 and M4 or that M4, the most
hydrophobic of all the putative transmembrane domains in
the AChR subunits, become extracellular in the assembled
receptor. Neither possibility seems likely.
An important question is whether the orientation assumed
by the newly synthesized subunits is identical to that of the
subunits in the mature AChR. Although a rearrangement of
transmembrane domains is theoretically possible, the do-
main structure of the AChR subunits makes this unlikely. All
of the transmembrane domains, even M2 which lines the
aqueous pore (24, 25, 42), are highly hydrophobic, and are
likely to be quite stable as transmembrane segments. We
cannot rule out the possibility that assembly might cause
other segments to insert into the membrane, giving rise to
additional transmembrane regions, but with the possible ex-
ception of the M6 and M7 segments on the amino-terminal
side of Ml, postulated by Criado et al. (12) to span the mem-
brane, no other segments of the subunit polypeptides are
plausible candidates for such a role. We have argued previ-
391ously that M6 and M7 are also unlikely to insert during as-
sembly (8).
Because of the high degree ofprimary sequence homology
between the AChR subunits and other members ofthe family
of ligand-gated ion channels, our conclusions can be ex-
tended to these molecules as well. The characterization of
specific conformational changes that accompany ligand
binding and desensitization await a more detailed analysis in-
volving the determination of the crystal structure of the
receptor in a variety of functional states. However, our
studies show that alternative strategies such as the use of
reporter domains can be very useful in the elucidation of the
basic topology of polytopic membrane proteins.
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